Aboriginal MD program meets graduation goal ahead of schedule
In 2002, UBC’s Aboriginal MD Admissions program set an unofficial goal of graduating 50 more Aboriginal MDs by 2020. Now, the ambitious goal has been reached five years early.
The key to stopping sarcomas’ spread
Poul Sorensen found a previously unknown protein pathway that enables tumour cells to withstand hypoxia — and cancer drugs.
Understanding “harm thoughts” in postpartum mothers
Nichole Fairbrother’s research aims to improve mental health care for postpartum mothers.
Epilepsy drug could help treat Alzheimer’s disease
Haakon Nygaard, the Fipke Professor in Alzheimer’s Research, tested a new, more potent anticonvulsant drug in mice, with promising results.
DNA near Huntington’s gene can dampen — or worsen — the disease
Blair Leavitt’s work lays the groundwork for drugs that could affect the gene’s expression.
Air pollution exposure in first year of life increases risk for allergies
The study by Professor Michael Brauer, in the School of Population and Public Health, sheds new light on the childhood risk of developing allergies.
A big step closer to changing blood types
Jayachandran Kizhakkedathu, in the Department of Pathology and Laboratory Medicine, removed most antigens in Type A and B blood, making it more like Type O, the universal donor type.
Med student creates art classes for people living with brain injuries
New idea tackles depression and social isolation while creating useable art work.
UBC’s Southern Medical Program prepares to graduate first students
The 32 MD students were taught at UBC Okanagan clinical sites in B.C.’s Interior.
“Chemo brain” is real, UBC researchers say
Physical Therapy Assistant Professor Kristin Campbell assisted with the study, which confirmed that people who received chemotherapy exhibit different patterns of electrical brain activity.